Mokuda O, Sakamoto Y, Kawagoe R, Shimizu N
Third Department of Internal Medicine, Teikyo University School of Medicine, Chiba, Japan.
Horm Metab Res. 1993 Jun;25(6):285-8. doi: 10.1055/s-2007-1002099.
The effects of arterial-portal glucose difference on the gluconeogenesis from lactate were studied using the bivascular perfused liver isolated from the fasted rat. The liver was cyclically perfused at flow rates of 14 ml/min from the portal vein and of 7 ml/min from the hepatic artery with the total volume of 35 ml of perfusion medium containing 2 mM glucose, 3 mM lactate and (U-14C)-lactate for 20 min. Glucose was infused at a rate of 27.75 mumol/min into the arterial cannula (A-experiment) or the portal cannula (P-experiment), making each arterial-portal glucose gradient of +3.96 mM (arterial glucose > portal glucose) and -1.98 mM (arterial glucose < portal glucose) throughout the experiment. Perfusate lactate concentration was lower in A-experiment than in P-experiment (1.40 +/- 0.25 vs 1.93 +/- 0.23 mM at 20 min, mean +/- SD, p < 0.05). Incorporation of radioactivity from (U-14C)-lactate into glucose carbon 1 in perfusate was 5.7 +/- 0.8% of total radioactivity per 20 min in A-experiment vs 2.8 +/- 0.6%/20 min in P-experiment (p < 0.01). These results suggest that the arterial-portal glucose difference is an important factor to regulate the hepatic gluconeogenesis.
利用从禁食大鼠分离出的双血管灌注肝脏,研究了动脉-门静脉葡萄糖差异对乳酸糖异生的影响。肝脏以14毫升/分钟的流速从门静脉和7毫升/分钟的流速从肝动脉进行循环灌注,灌注介质总体积为35毫升,其中含有2毫摩尔葡萄糖、3毫摩尔乳酸和(U-14C)-乳酸,持续20分钟。以27.75微摩尔/分钟的速率将葡萄糖注入动脉插管(A实验)或门静脉插管(P实验),在整个实验过程中使每个动脉-门静脉葡萄糖梯度分别为+3.96毫摩尔(动脉葡萄糖>门静脉葡萄糖)和-1.98毫摩尔(动脉葡萄糖<门静脉葡萄糖)。A实验中灌注液乳酸浓度低于P实验(20分钟时为1.40±0.25毫摩尔对1.93±0.23毫摩尔,均值±标准差,p<0.05)。在A实验中,灌注液中(U-14C)-乳酸的放射性掺入葡萄糖碳1的量为每20分钟总放射性的5.7±0.8%,而在P实验中为2.8±0.6%/20分钟(p<0.01)。这些结果表明,动脉-门静脉葡萄糖差异是调节肝脏糖异生的一个重要因素。